Novartis Ag Stock Odds of Future Pink Sheet Price Finishing Under 84.28

NVSEF Stock  USD 95.11  4.87  5.40%   
Novartis' future price is the expected price of Novartis instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Novartis AG performance during a given time horizon utilizing its historical volatility. Check out Novartis Backtesting, Novartis Valuation, Novartis Correlation, Novartis Hype Analysis, Novartis Volatility, Novartis History as well as Novartis Performance.
  
Please specify Novartis' target price for which you would like Novartis odds to be computed.

Novartis Target Price Odds to finish below 84.28

The tendency of Novartis Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 84.28  or more in 90 days
 95.11 90 days 84.28 
near 1
Based on a normal probability distribution, the odds of Novartis to drop to $ 84.28  or more in 90 days from now is near 1 (This Novartis AG probability density function shows the probability of Novartis Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Novartis AG price to stay between $ 84.28  and its current price of $95.11 at the end of the 90-day period is about 17.38 .
Assuming the 90 days horizon Novartis has a beta of 0.0781. This indicates as returns on the market go up, Novartis average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Novartis AG will be expected to be much smaller as well. Additionally Novartis AG has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   Novartis Price Density   
       Price  

Predictive Modules for Novartis

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Novartis AG. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novartis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
93.3795.1196.85
Details
Intrinsic
Valuation
LowRealHigh
82.1083.84104.62
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Novartis. Your research has to be compared to or analyzed against Novartis' peers to derive any actionable benefits. When done correctly, Novartis' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Novartis AG.

Novartis Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Novartis is not an exception. The market had few large corrections towards the Novartis' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Novartis AG, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Novartis within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.18
β
Beta against NYSE Composite0.08
σ
Overall volatility
4.72
Ir
Information ratio -0.15

Novartis Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Novartis for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Novartis AG can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Novartis AG generated a negative expected return over the last 90 days

Novartis Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Novartis Pink Sheet often depends not only on the future outlook of the current and potential Novartis' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Novartis' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.1 B

Novartis Technical Analysis

Novartis' future price can be derived by breaking down and analyzing its technical indicators over time. Novartis Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Novartis AG. In general, you should focus on analyzing Novartis Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Novartis Predictive Forecast Models

Novartis' time-series forecasting models is one of many Novartis' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Novartis' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Novartis AG

Checking the ongoing alerts about Novartis for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Novartis AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Novartis AG generated a negative expected return over the last 90 days
Check out Novartis Backtesting, Novartis Valuation, Novartis Correlation, Novartis Hype Analysis, Novartis Volatility, Novartis History as well as Novartis Performance.
Note that the Novartis AG information on this page should be used as a complementary analysis to other Novartis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Novartis Pink Sheet analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
CEOs Directory
Screen CEOs from public companies around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.